MedicarePartD.guide

A non-government resource built from CMS public data

memantine on SilverScript Choice (S5601-034)

generic Namenda

Covered, with prior authorization required.

Tier 3 (preferred brand). Quantity limit of 60 per 30 days.

$0.57
Patient pays / month, after deductible
$3.16
Patient pays / month, before the $615.00 deductible
$1.71
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

MEMANTINE HYDROCHLORIDE 10 mg Tablet at a preferred retail pharmacy, from the plan's negotiated price of $3.16 for a month. Other covered strengths are listed below.

Prior authRequired on all 7 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 7 covered strengths and forms
FormTierPatient pays / monthLimits
MEMANTINE HYDROCHLORIDE 5 mg Tablet, Film Coated3$0.73PA · 60 per 30 days
MEMANTINE HYDROCHLORIDE 10 mg Tablet3$0.57PA · 60 per 30 days
MEMANTINE 2 mg/mL Solution3$27.40PA · 360 per 30 days
MEMANTINE HYDROCHLORIDE 28 mg Capsule, Extended Release433%PA
MEMANTINE HYDROCHLORIDE 7 mg Capsule, Extended Release433%PA
MEMANTINE HYDROCHLORIDE 14 mg Capsule, Extended Release433%PA
MEMANTINE HYDROCHLORIDE 21 mg Capsule, Extended Release433%PA

Other Alzheimer's drugs on this plan

Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5601-034